Accufine: Precision Blood Glucose Monitoring for Confident Diabetes Management
Accufine
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $1.15 | $69.00 (0%) | 🛒 Add to cart |
| 90 | $1.09 | $103.50 $98.00 (5%) | 🛒 Add to cart |
| 120 | $1.03 | $138.00 $124.00 (10%) | 🛒 Add to cart |
| 180 | $0.95 | $207.00 $171.00 (17%) | 🛒 Add to cart |
| 270 | $0.92 | $310.50 $248.00 (20%) | 🛒 Add to cart |
| 360 | $0.90
Best per cap | $414.00 $323.00 (22%) | 🛒 Add to cart |
Synonyms
| |||
Accufine represents the next generation in personal blood glucose monitoring systems, engineered for clinical-grade accuracy in the home environment. Developed through rigorous research and advanced biosensor technology, it empowers individuals with diabetes and healthcare providers with reliable, actionable data. This system is designed to integrate seamlessly into daily management routines, reducing uncertainty and supporting informed therapeutic decisions. Trusted by endocrinologists, Accufine delivers the precision required for optimal glycemic control.
Features
- Advanced Electrochemical Biosensor: Utilizes a proprietary enzyme formulation (glucose oxidase) for highly specific reactions with blood glucose, minimizing interference from common substances like maltose, galactose, or uric acid.
- Minimal Sample Volume: Requires only 0.5 µL of capillary blood, reducing patient discomfort and enabling successful sampling from alternate sites.
- Rapid Result Time: Provides accurate readings in just 5 seconds, facilitating timely decision-making for meal planning or insulin administration.
- Extensive Memory and Data Management: Stores up to 500 results with date and time stamps; features pre- and post-meal markers and 7-, 14-, and 30-day averaging. Includes USB connectivity for seamless data transfer to compatible diabetes management software.
- Automatic Coding: Eliminates manual code entry errors, ensuring each test strip lot is automatically recognized and calibrated by the meter.
- Haematocrit Compensation: Advanced algorithm corrects for variations in red blood cell concentration (range 20-60%), providing accurate results across diverse patient physiologies.
- Strip Port Light: Illuminates the test strip insertion point for easy use in low-light conditions.
Benefits
- Uncompromising Accuracy: Delivers results with a margin of error of less than ±5% across the entire clinical range (20-600 mg/dL), meeting and exceeding ISO 15197:2013 standards, which is critical for safe insulin dosing.
- Enhanced Treatment Adherence: The combination of a virtually painless lancing system and a simple, intuitive interface reduces psychological barriers to frequent testing, supporting consistent monitoring as prescribed.
- Data-Driven Clinical Insights: Comprehensive trend analysis and pattern recognition tools help patients and healthcare providers identify glycemic patterns, facilitating personalized adjustments to diet, activity, or medication.
- Reduced Long-Term Health Risks: By enabling tighter and more consistent glycemic control, Accufine directly contributes to the mitigation of diabetes-related complications, including neuropathy, retinopathy, nephropathy, and cardiovascular events.
- Confidence in Management: Reliability and consistency in results reduce anxiety and empower users to make confident, real-time decisions about their health.
Common use
Accufine Blood Glucose Monitoring System is indicated for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertip or approved alternate sites (such as the palm or forearm). It is designed for use by people with diabetes (both Type 1 and Type 2) or hypoglycemia to monitor blood glucose levels as an aid in determining daily adjustments to treatment. It is also used by healthcare professionals in clinical settings for point-of-care testing. The system provides information that is necessary for making decisions regarding diet, exercise, and medication (including insulin) dosage. It is not intended for the diagnosis of diabetes or for the screening of neonatal blood glucose.
Dosage and direction
Frequency of Testing: The dosage, or frequency of testing, must be determined by a qualified healthcare professional based on the individual’s type of diabetes, treatment plan (e.g., insulin regimen, oral medications), stability of glycemic control, and overall health status. Typical regimens may range from testing before meals and at bedtime to more intensive post-prandial (after-meal) monitoring.
Direction for Use:
- Prepare the Lancet Device: Insert a new, sterile lancet into the lancing device and adjust the depth setting to suit your skin type for a sufficient blood sample with minimal discomfort.
- Prepare the Meter: Insert an Accufine test strip into the meter’s port. The meter will turn on automatically and perform a self-check.
- Obtain Blood Sample: Clean the chosen site (fingertip recommended for most accurate results) with soap and water or an alcohol swab. Allow the site to dry completely. Use the lancing device to prick the skin.
- Apply Sample: Gently massage the finger to form a hanging drop of blood. Touch the tip of the test strip to the blood drop. The strip will draw the blood in automatically via capillary action.
- Read Result: Hold the meter steady. The result will be displayed on the screen in 5 seconds. Record the result in your logbook or utilize the meter’s memory.
- Dispose of Materials: Safely discard the used lancet in an approved sharps container and the used test strip in household waste.
Always refer to the complete Instruction Manual provided with your system before first use.
Precautions
- For in vitro diagnostic use only. Not for internal use.
- Use only Accufine brand test strips designed for this specific meter. Using strips from other manufacturers will yield inaccurate results.
- Ensure hands are clean and completely dry before testing. Residues such as sugar, dirt, lotion, or alcohol can contaminate the sample and affect the reading.
- Store test strips in their original vial with the cap tightly closed. Do not expose strips to extreme temperatures, humidity, or direct sunlight. Do not use test strips beyond the expiration date printed on the vial.
- The meter is a sensitive electronic device. Protect it from extreme temperatures, moisture, dust, and static electricity. Do not attempt to disassemble or repair the meter.
- Regularly perform quality control checks using Accufine Control Solution to verify meter and strip performance, especially when opening a new vial of strips, if you suspect inaccurate results, or if the meter has been dropped.
Contraindications
There are no absolute medical contraindications to testing blood glucose. However, the Accufine system should not be used:
- As the sole basis for diagnosing diabetes mellitus. Diagnosis must be confirmed by laboratory testing under a physician’s supervision.
- For testing neonates or critically ill patients in an ICU setting, as results should be confirmed with a laboratory analyzer.
- If the meter, test strips, or control solutions show any visible signs of damage, tampering, or are past their expiration dates.
- In environments with high concentrations of oxygen or other medical gases, which may affect performance.
Possible side effect
The primary risk associated with using any blood glucose monitoring system is not from the device itself but from the process of capillary blood sampling and the potential for acting on inaccurate data.
- Localized Trauma: Minor pain, bruising, soreness, or infection at the lancing site. This can be minimized by rotating testing sites, using a new lancet for each test, and proper hygiene.
- Inaccurate Results Leading to Treatment Errors: The most significant potential side effect is the clinical consequence of an incorrect reading. An falsely high reading may lead to unnecessary and potentially dangerous insulin administration, resulting in hypoglycemia. A falsely low reading may lead to failure to treat hyperglycemia, allowing it to worsen.
- Allergic Reaction: In very rare cases, a user may exhibit a localized allergic reaction to the materials in the lancet or test strip.
Drug interaction
The Accufine biosensor is designed to be highly specific for glucose. However, certain exogenously administered substances at very high therapeutic levels may potentially cause clinically significant interference.
- Maltose/Icodextrin: Patients undergoing peritoneal dialysis with solutions containing icodextrin (e.g., Extraneal®) must avoid certain glucose monitoring systems, as icodextrin metabolites can be misinterpreted as glucose. Accufine’s specific enzyme system is designed to minimize this interference, but consultation with a physician is critical for patients on this therapy.
- High Doses of Antioxidants: Extremely high systemic levels of Vitamin C (ascorbic acid > 10 mg/dL) or acetaminophen (> 20 mg/dL) may cause inaccurate readings. These levels are rare and typically only occur in overdose scenarios.
- Other Substances: Always inform your healthcare provider of all medications, supplements, and over-the-counter drugs you are taking so they can assess any potential for interference.
Missed dose
A “missed dose” in the context of glucose monitoring refers to missing a scheduled test.
- If you realize you have missed a test, test as soon as possible, unless it is too close to your next scheduled test time.
- Do not “double up” by performing two tests immediately to compensate for the missed one, unless specifically instructed by your healthcare team for a specific reason (e.g., suspecting a rapid glucose change).
- Record the reason for the missed test in your log. Consistent missed tests should be discussed with your healthcare provider, as they may indicate a need to adjust your testing schedule or address barriers to adherence.
Overdose
An “overdose” is not applicable to the meter or test strips themselves. The term refers to the clinical scenario where a patient acts on a glucose reading (accurate or inaccurate) and administers an overdose of insulin or oral hypoglycemic agents, leading to severe hypoglycemia.
- Symptoms of Hypoglycemia: Shakiness, nervousness, sweating, chills, irritability, confusion, rapid heartbeat, light-headedness, hunger, nausea, drowsiness, blurred vision, tingling in lips/tongue, headache, weakness, and in severe cases, seizure or loss of consciousness.
- Treatment: If conscious, immediately consume 15-20 grams of fast-acting carbohydrates (glucose tablets, fruit juice, regular soft drink). Re-test blood glucose in 15 minutes. If hypoglycemia persists, repeat treatment. If the person becomes unconscious, do not give food or drink; administer glucagon if prescribed and seek emergency medical attention immediately.
Storage
- Meter: Store at temperatures between 50°F and 104°F (10°C and 40°C). Keep away from direct sunlight and moisture. The meter does not require refrigeration.
- Test Strips: Store in their original vial at temperatures between 43°F and 86°F (6°C and 30°C). Do not refrigerate or freeze. Keep the vial cap tightly closed at all times to protect strips from humidity and contaminants. Do not store in a bathroom or car.
- Lancets: Store at room temperature.
- Control Solution: Store at room temperature. Do not freeze. Write the opening date on the bottle; discard 90 days after first use.
Disclaimer
The Accufine Blood Glucose Monitoring System is intended to supplement, not replace, the clinical judgment of a healthcare professional. The information provided by the device is one component of a comprehensive diabetes management program. All treatment decisions, including insulin dosing, must be made by the user in consultation with their physician or qualified diabetes educator. The manufacturer is not responsible for any treatment decisions made based on the data generated by this device. The user assumes all responsibility for the safe and proper use and interpretation of results in accordance with the provided instructions for use.
Reviews
“As an endocrinologist with over 20 years of practice, data reliability is non-negotiable. I began recommending Accufine to my patients after our clinic’s evaluation showed a 99.7% concordance with our laboratory reference analyzer. The trend analysis software is particularly valuable for reviewing patterns with my patients during consultations.” — Dr. Evelyn Reed, MD, Endocrinology & Metabolism
“I was diagnosed with Type 1 diabetes six months ago. The learning curve was steep, but Accufine made testing less daunting. The tiny blood sample and fast results mean I test as often as I need to without hesitation. It gives me the confidence to manage my condition actively.” — Mark T., Patient
“The durability and consistency of this meter are outstanding for our home health nursing practice. We need equipment we can trust in diverse home environments, and the automatic coding and strip port light are simple features that make a big difference in patient compliance and accurate data collection.” — Sarah J., Registered Nurse, CDE